-
Science is looking at a wireless microchip implant, with remote drug delivery control, that is designed to last up to 16 years.
-
This statement from the practice committee of the American Society for Reproductive Medicine provides an update to what is known about pelvic adhesions and gynecologic surgery.
-
Three to 5% of patients at term will have breech presentations, and in most countries 90% of these patients will be delivered by Cesarean section.
-
Based on results of two systematic evidence reviews, the USPSTF issued a revised statement regarding recommendations for breast cancer screening.
-
-
In this issue: Statin and niacin increase HDL-C, omeprazole reduces effectiveness of clopidogrel, darbe-poetin increases risk of stroke, statins decrease risk of gallstone disease, FDA Actions.
-
Angiogenesis is an important process, which sustains ovarian cancer growth. Cediranib, a potent, oral tyrosine kinase inhibitor (TKI) of vascular endothelial growth factor receptor (VEGFR) 1, 2, and 3, and c-kit, has shown promise in other solid tumors, including non-small cell lung cancer.
-
-
In a prospective randomized trial, use of a post-operative drain was associated with lower mortality and less recurrence in the treatment of chronic subdural hematoma (SDH)
-
Combination therapies may be better than single agents for neuropathic pain relief, but side effects are a limiting factor.